DK455088D0 - Syntetiske receptoranaloger - Google Patents

Syntetiske receptoranaloger

Info

Publication number
DK455088D0
DK455088D0 DK455088A DK455088A DK455088D0 DK 455088 D0 DK455088 D0 DK 455088D0 DK 455088 A DK455088 A DK 455088A DK 455088 A DK455088 A DK 455088A DK 455088 D0 DK455088 D0 DK 455088D0
Authority
DK
Denmark
Prior art keywords
pct
galabiose
synthetic receptor
receptor analogs
sec
Prior art date
Application number
DK455088A
Other languages
Danish (da)
English (en)
Inventor
Hans Goeran Magnusson
Jan Olof Kihlberg
Original Assignee
Symbicom Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbicom Ab filed Critical Symbicom Ab
Priority to DK455088A priority Critical patent/DK455088D0/da
Publication of DK455088D0 publication Critical patent/DK455088D0/da
Priority to IL9126989A priority patent/IL91269A/en
Priority to US07/689,077 priority patent/US5474986A/en
Priority to AT89909545T priority patent/ATE113056T1/de
Priority to JP1508951A priority patent/JPH04506509A/ja
Priority to DE68918944T priority patent/DE68918944T2/de
Priority to KR1019900700766A priority patent/KR900701807A/ko
Priority to CA000608146A priority patent/CA1332234C/en
Priority to PCT/DK1989/000192 priority patent/WO1990001488A1/en
Priority to EP89909545A priority patent/EP0428605B1/en
Priority to AU40749/89A priority patent/AU634976B2/en
Priority to NO910503A priority patent/NO176518C/no
Priority to DK022891A priority patent/DK22891A/da
Priority to FI910653A priority patent/FI93016C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Prostheses (AREA)
DK455088A 1988-08-12 1988-08-12 Syntetiske receptoranaloger DK455088D0 (da)

Priority Applications (14)

Application Number Priority Date Filing Date Title
DK455088A DK455088D0 (da) 1988-08-12 1988-08-12 Syntetiske receptoranaloger
IL9126989A IL91269A (en) 1988-08-12 1989-08-09 Galbioside analogues for use as biological receptors and pharmaceutical preparations containing them
AU40749/89A AU634976B2 (en) 1988-08-12 1989-08-11 Galactopyranosyl-galactopyranosyl receptor analogues
KR1019900700766A KR900701807A (ko) 1988-08-12 1989-08-11 갈라비오 사이드 아날로그, 이를 포함한 약학적 조성물 및 그용도
AT89909545T ATE113056T1 (de) 1988-08-12 1989-08-11 Künstliche rezeptor-analoge.
JP1508951A JPH04506509A (ja) 1988-08-12 1989-08-11 合成受容体類似体
DE68918944T DE68918944T2 (de) 1988-08-12 1989-08-11 Künstliche rezeptor-analoge.
US07/689,077 US5474986A (en) 1988-08-12 1989-08-11 Method for treating galabiose-binding bacteria infections
CA000608146A CA1332234C (en) 1988-08-12 1989-08-11 Synthetic receptor analogues
PCT/DK1989/000192 WO1990001488A1 (en) 1988-08-12 1989-08-11 Synthetic receptor analogues
EP89909545A EP0428605B1 (en) 1988-08-12 1989-08-11 Synthetic receptor analogues
NO910503A NO176518C (no) 1988-08-12 1991-02-08 Analogifremgangsmåte til fremstilling av terapeutisk aktive syntetiske reseptoranaloger
DK022891A DK22891A (da) 1988-08-12 1991-02-11 Syntetiske receptoranaloger
FI910653A FI93016C (sv) 1988-08-12 1991-02-11 Syntetiska receptoranaloger

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK455088A DK455088D0 (da) 1988-08-12 1988-08-12 Syntetiske receptoranaloger

Publications (1)

Publication Number Publication Date
DK455088D0 true DK455088D0 (da) 1988-08-12

Family

ID=8134551

Family Applications (1)

Application Number Title Priority Date Filing Date
DK455088A DK455088D0 (da) 1988-08-12 1988-08-12 Syntetiske receptoranaloger

Country Status (12)

Country Link
US (1) US5474986A (sv)
EP (1) EP0428605B1 (sv)
JP (1) JPH04506509A (sv)
KR (1) KR900701807A (sv)
AT (1) ATE113056T1 (sv)
AU (1) AU634976B2 (sv)
CA (1) CA1332234C (sv)
DE (1) DE68918944T2 (sv)
DK (1) DK455088D0 (sv)
FI (1) FI93016C (sv)
IL (1) IL91269A (sv)
WO (1) WO1990001488A1 (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4119472A1 (de) * 1991-06-13 1992-12-17 Merck Patent Gmbh Verfahren zur stereoselektiven herstellung von gal-(alpha)(1-3)/gal-(beta)(1-4)/glcnac-trisacchariden und von neuen (beta)(1-3)-verknuepften oligolactosaminen ueber neue partiell alkylierte glykale
US5409902A (en) * 1991-12-31 1995-04-25 Lever Brothers Company Oral hygiene compositions containing glyceroglycolipids as antiplaque compounds
EP0601417A3 (de) * 1992-12-11 1998-07-01 Hoechst Aktiengesellschaft Physiologisch verträglicher und physiologisch abbaubarer, Kohlenhydratrezeptorblocker auf Polymerbasis, ein Verfahren zu seiner Herstellung und seine Verwendung
TW307775B (en) * 1994-02-15 1997-06-11 Novartis Erfind Verwalt Gmbh Unsaturated carbohydrate derivatives, polymers thereof and their use
US6596707B2 (en) * 2001-05-24 2003-07-22 Abbott Laboratories Monovalent saccharides and uses thereof
US7790010B2 (en) * 2002-12-20 2010-09-07 University Of Maryland, College Park Spatially selective deposition of polysaccharide layer onto patterned template
EP2497478A3 (en) * 2003-12-05 2012-11-07 Children's Hospital Medical Center Oligosaccaride compositions and use thereof in the treatment of infection
US7871785B2 (en) 2007-09-07 2011-01-18 Children's Hospital Medical Center Use of secretor, Lewis and sialyl antigen levels in clinical samples as predictors of risk for disease
DK2451462T3 (en) 2009-07-06 2017-12-11 Children's Hospital Medical Center Inhibition of inflammation with milk oligosaccharides
JP6187893B2 (ja) * 2011-07-08 2017-08-30 群栄化学工業株式会社 保湿剤の製造方法
US10626460B2 (en) 2013-02-21 2020-04-21 Children's Hospital Medical Center Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease
WO2016176484A1 (en) 2015-04-28 2016-11-03 Children's Hospital Medical Center Use of oligosaccharide compositions to enhance weight gain
CN111566117A (zh) 2017-12-29 2020-08-21 糖模拟物有限公司 E-选择蛋白和半乳凝素-3的异双功能抑制剂
CN118373810A (zh) 2018-12-27 2024-07-23 糖模拟物有限公司 抑制c-糖苷的半乳凝素-3
WO2020139962A1 (en) 2018-12-27 2020-07-02 Glycomimetics, Inc. Heterobifunctional inhibitors of e-selectin and galectin-3

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8001748L (sv) * 1980-03-05 1981-09-06 Kaellenius Gunilla Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik
EP0089940A1 (en) * 1982-03-23 1983-09-28 BioCarp AB Compositions for therapeutic or diagnostic use containing oligosaccharides
SE8203925D0 (sv) * 1982-06-23 1982-06-23 Svenska Sockerfabriks Ab New and novel glycosides, glycoconjugates and processes for their preparation
SE8304007D0 (sv) * 1983-07-15 1983-07-15 Karlsson Karl Anders Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
SE8406626D0 (sv) * 1984-12-27 1984-12-27 Bio Carb Ab Forening och komposition for terapeutisk eller diagnostisk anvendning jemte anvendning av sadan forening och komposition for terapeutisk behandling och isolering av shigatoxin
DK17685D0 (da) * 1985-01-14 1985-01-14 Hans Goeran Magnusson Glycosidderivater

Also Published As

Publication number Publication date
JPH04506509A (ja) 1992-11-12
WO1990001488A1 (en) 1990-02-22
AU4074989A (en) 1990-03-05
EP0428605B1 (en) 1994-10-19
DE68918944D1 (de) 1994-11-24
US5474986A (en) 1995-12-12
DE68918944T2 (de) 1995-05-11
CA1332234C (en) 1994-10-04
EP0428605A1 (en) 1991-05-29
AU634976B2 (en) 1993-03-11
KR900701807A (ko) 1990-12-04
FI93016B (sv) 1994-10-31
ATE113056T1 (de) 1994-11-15
IL91269A (en) 1994-11-11
FI93016C (sv) 1995-02-10
FI910653A0 (sv) 1991-02-11

Similar Documents

Publication Publication Date Title
FI910653A0 (sv) Syntetiska receptoranaloger
ES2148476T3 (es) Derivados de azabicicloalcano n-substituidos como neurolepticos asf.
MY129994A (en) Novel siloxane derivatives, producing method thereof and agents including siloxane derivative
TW263423B (sv)
SE8503680D0 (sv) Indolderivat
NO952494D0 (no) Nytt protein fra urin med betegnelse komponent B
DK0473671T3 (da) Anvendelse af sigma-receptorligander til fremstilling af et anxiolytisk middel
PT84826A (de) Verstellvorrichtung insbesondere fur verstellfure stuhle
ES2117976T3 (es) Preparacion de derivados n-acetil neuraminicos.
ES2080140T3 (es) Derivados de eritromicina.
DK0561846T3 (da) 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
FI915655A0 (fi) Somatotropiner med alterneringar i alfahelixregionen 3, alfahelixregionen 2, kombinationer daerav och i kombination med andra mutationer.
CS9100438A2 (en) New derivative of beta-phenylisoserine, method of its preparation and its application
ATE204752T1 (de) Therapeutische anwendungen von 2',5'- oligoadenylat-derivaten
ES2028871T3 (es) Un procedimiento para la preparacion de un glicosido de antraciclina. .
DK218388A (da) Aktivt princip isoleret fra hajvaev
GR3005566T3 (sv)
FI901213A0 (fi) Substituerade (kinolin-2-ylmetoxi) fenyl-n,n'-sulfonylurinaemnen, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
ATE41927T1 (de) Phenylalkylamine - bioregulatoren.
DK0683776T3 (da) Substituerede heteroarylalkylthiopyridiner til bekæmpelse af Helicobacter-bakterier
ES2119814T3 (es) Metodo para la separacion de mezclas de gibberelinas.
GR1001309B (el) Μεθοδος παρασκευης παραγωγου ενωσεως της διχλωροανιλινης.
ZA929176B (en) Aminoalkyl-substituted 5,6-dihydro-dibenz(b e)azepine-6,11-dione-11-oximes.
DE69104363D1 (de) Vinylsulfonyl pristinamycine und deren herstellung.
NO974687D0 (no) Kondenserte <beta>-carboliner

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment